MFIM
Mesirow Financial Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,996
| Closed | -$206K | – | 539 |
|
2025
Q1 | $206K | Buy |
+2,996
| New | +$206K | ﹤0.01% | 537 |
|
2024
Q1 | – | Sell |
-3,862
| Closed | -$218K | – | 529 |
|
2023
Q4 | $218K | Hold |
3,862
| – | – | 0.01% | 506 |
|
2023
Q3 | $224K | Sell |
3,862
-3,030
| -44% | -$176K | 0.98% | 67 |
|
2023
Q2 | $371K | Hold |
6,892
| – | – | 1.57% | 15 |
|
2023
Q1 | $274K | Hold |
6,892
| – | – | 1.13% | 45 |
|
2022
Q4 | $277K | Hold |
6,892
| – | – | 1.16% | 39 |
|
2022
Q3 | $222K | Hold |
6,892
| – | – | 1.06% | 52 |
|
2022
Q2 | $204K | Buy |
+6,892
| New | +$204K | 0.99% | 63 |
|
2022
Q1 | – | Sell |
-12,277
| Closed | -$566K | – | 82 |
|
2021
Q4 | $566K | Hold |
12,277
| – | – | 1.63% | 18 |
|
2021
Q3 | $403K | Buy |
12,277
+3,303
| +37% | +$108K | 1.19% | 51 |
|
2021
Q2 | $315K | Buy |
8,974
+24
| +0.3% | +$842 | 0.8% | 76 |
|
2021
Q1 | $323K | Sell |
8,950
-380
| -4% | -$13.7K | 0.88% | 68 |
|
2020
Q4 | $271K | Sell |
9,330
-103
| -1% | -$2.99K | 0.86% | 68 |
|
2020
Q3 | $266K | Buy |
9,433
+1,252
| +15% | +$35.3K | 1.14% | 62 |
|
2020
Q2 | $265K | Buy |
8,181
+1,639
| +25% | +$53.1K | 1.25% | 49 |
|
2020
Q1 | $267K | Buy |
6,542
+819
| +14% | +$33.4K | 1.68% | 19 |
|
2019
Q4 | $353K | Sell |
5,723
-1,926
| -25% | -$119K | 1.49% | 38 |
|
2019
Q3 | $557K | Sell |
7,649
-490
| -6% | -$35.7K | 2.34% | 5 |
|
2019
Q2 | $673K | Sell |
8,139
-2,176
| -21% | -$180K | 2.46% | 10 |
|
2019
Q1 | $728K | Buy |
10,315
+3,288
| +47% | +$232K | 2.89% | 1 |
|
2018
Q4 | $316K | Hold |
7,027
| – | – | 2.04% | 20 |
|
2018
Q3 | $397K | Sell |
7,027
-2,228
| -24% | -$126K | 2.05% | 17 |
|
2018
Q2 | $618K | Buy |
9,255
+2,991
| +48% | +$200K | 2.75% | 4 |
|
2018
Q1 | $365K | Buy |
6,264
+2,768
| +79% | +$161K | 1.54% | 32 |
|
2017
Q4 | $225K | Sell |
3,496
-7,600
| -68% | -$489K | 1.02% | 52 |
|
2017
Q3 | $582K | Buy |
11,096
+280
| +3% | +$14.7K | 2.74% | 5 |
|
2017
Q2 | $506K | Buy |
+10,816
| New | +$506K | 2.39% | 12 |
|